Wednesday, November 25, 2009, 9:36am EST - Canadian Markets close in 6 hours and 24 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

MedaSorb Technologies Corporation (MSBT.OB)

 On Nov 24: 0.17 USD   0.00 (0.00%)  
MORE ON MSBT.OB
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
MEDASORB TECHNOLOGS (OTC BB:MSBT.OB) Delayed quote dataEdit
Last Trade: 0.17 USD
Trade Time: Nov 24
Change: 0.00 (0.00%)
Prev Close: 0.17
Open: N/A
Bid: 0.17 x 5000
Ask: 0.17 x 5000
1y Target Est: N/A
Day's Range: N/A - N/A
52wk Range: 0.04 - 0.44
Volume: 0
Avg Vol (3m): 1,430,400
Market Cap: 7.06M
P/E (ttm): N/A
EPS (ttm): -0.13
Div & Yield: N/A (N/A%)
MedaSorb Technologies Corporation (MSBT.OB)
1d  5d  3m  6m  1y  2y  5y 
 Add MSBT.OB to Portfolio   Download Data

HEADLINES
• MEDASORB TECHNOLOGIES CORP Financials
EDGAR Online Financials (Thu, Nov 19)
• MedaSorb Technologies Corporation Provides Clinical Update
Marketwire (Fri, Nov 13)
• MedaSorb Technologies Corporation Announces Q3 2009 Results and Files Form 10-Q, Quarterly Report
Marketwire (Fri, Nov 13)
• MEDASORB TECHNOLOGIES CORP Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Nov 13)
• MEDASORB TECHNOLOGIES CORP Files SEC form 8-K, Unregistered Sale of Equity Securities, Regulation FD Disclosure, Fina
EDGAR Online (Fri, Oct 9)
• MedaSorb Technologies Corporation Raises $1.3M in Series B Warrant Exercise
Marketwire (Fri, Oct 9)
• MEDASORB TECHNOLOGIES CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
EDGAR Online (Tue, Sep 15)
• MedaSorb Technologies Corporation to Present at the Rodman & Renshaw Global Investment Conference
Marketwire (Wed, Aug 19)
• MEDASORB TECHNOLOGIES CORP Files SEC form 10-Q, Quarterly Report
EDGAR Online (Fri, Aug 14)
• / CORRECTION - MedaSorb and CytoSorbents CEO Featured in Interviews by The Wall Street Transcript and CEO-CFO Interviews
Marketwire (Fri, Jul 17)
More Headlines for MSBT.OB...
BUSINESS SUMMARY
Medasorb Technologies Corporation, a development stage medical device company, focuses on developing and commercializing blood purification technologies that would remove middle molecular weight toxins from circulating blood and physiologic fluids.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices